PHAS - PhaseBio Pharmaceuticals GAAP EPS of -$0.34 misses by $0.03 revenue of $0.21M misses by $0.29M
- PhaseBio Pharmaceuticals press release ( NASDAQ: PHAS ): Q2 GAAP EPS of -$0.34 misses by $0.03 .
- Revenue of $0.21M (-98.0% Y/Y) misses by $0.29M .
- Shares -0.86% PM.
For further details see:
PhaseBio Pharmaceuticals GAAP EPS of -$0.34 misses by $0.03, revenue of $0.21M misses by $0.29M